Meeder Asset Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,078
| Closed | -$6K | – | 2363 |
|
|
2022
Q1 | $6K | Buy |
+2,078
| New | +$6K | ﹤0.01% | 1740 |
|
|
2021
Q4 | – | Sell |
-11,457
| Closed | -$81K | – | 2001 |
|
|
2021
Q3 | $81K | Buy |
11,457
+422
| +4% | +$2.98K | ﹤0.01% | 953 |
|
|
2021
Q2 | $101K | Buy |
+11,035
| New | +$101K | ﹤0.01% | 906 |
|
|
2020
Q4 | – | Sell |
-585
| Closed | -$5K | – | 2131 |
|
|
2020
Q3 | $5K | Sell |
585
-944
| -62% | -$8.07K | ﹤0.01% | 1581 |
|
|
2020
Q2 | $15K | Buy |
1,529
+600
| +65% | +$5.89K | ﹤0.01% | 1210 |
|
|
2020
Q1 | $8K | Sell |
929
-4,029
| -81% | -$34.7K | ﹤0.01% | 1623 |
|
|
2019
Q4 | $43K | Buy |
4,958
+3,119
| +170% | +$27.1K | ﹤0.01% | 1069 |
|
|
2019
Q3 | $20K | Buy |
1,839
+1,155
| +169% | +$12.6K | ﹤0.01% | 1313 |
|
|
2019
Q2 | $9K | Buy |
684
+581
| +564% | +$7.65K | ﹤0.01% | 1495 |
|
|
2019
Q1 | $4K | Sell |
103
-37
| -26% | -$1.44K | ﹤0.01% | 1450 |
|
|
2018
Q4 | $3K | Buy |
140
+16
| +13% | +$343 | ﹤0.01% | 1520 |
|
|
2018
Q3 | $6K | Buy |
124
+47
| +61% | +$2.27K | ﹤0.01% | 1298 |
|
|
2018
Q2 | $4.56K | Buy |
+77
| New | +$4.56K | ﹤0.01% | 1297 |
|
|
2018
Q1 | – | Sell |
-366
| Closed | -$37K | – | 1699 |
|
|
2017
Q4 | $37K | Buy |
366
+278
| +316% | +$28.1K | ﹤0.01% | 760 |
|
|
2017
Q3 | $11K | Sell |
88
-11
| -11% | -$1.38K | ﹤0.01% | 1064 |
|
|
2017
Q2 | $9K | Sell |
99
-82
| -45% | -$7.46K | ﹤0.01% | 1025 |
|
|
2017
Q1 | $7K | Sell |
181
-323
| -64% | -$12.5K | ﹤0.01% | 960 |
|
|
2016
Q4 | $15K | Buy |
+504
| New | +$15K | ﹤0.01% | 691 |
|